THE SQUALESTATINS - NOVEL INHIBITORS OF SQUALENE SYNTHASE - ENZYME-INHIBITORY ACTIVITIES AND IN-VIVO EVALUATION OF C1-MODIFIED ANALOGS

被引:20
作者
PROCOPIOU, PA
BAILEY, EJ
BAMFORD, MJ
CRAVEN, AP
DYMOCK, BW
HOUSTON, JG
HUTSON, JL
KIRK, BE
MCCARTHY, AD
SAREEN, M
SCICINSKI, JJ
SHARRATT, PJ
SNOWDEN, MA
WATSON, NS
WILLIAMS, RJ
机构
[1] GLAXO GRP RES LTD,DEPT BIOCHEM TARGETS,GREENFORD UB6 0HE,MIDDX,ENGLAND
[2] GLAXO GRP RES LTD,DEPT MOLEC SCI,GREENFORD UB6 0HE,MIDDX,ENGLAND
关键词
D O I
10.1021/jm00046a011
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Squalestatin analogues modified in the C1 side chain were prepared and evaluated for their ability to inhibit rat liver microsomal and Candida squalene synthase (SQS) in vitro. While maintaining the 4,6-dimethyloctenoate or 4,6-dimethyloctanoate ester groups at C6, a number of modifications to the C1 side chain were well tolerated. However, in the absence of the C6 ester group, similar modifications to the C1 side chain caused substantial loss of activity. Compounds were also evaluated for their ability to inhibit cholesterol biosynthesis in vivo in rats and to reduce serum cholesterol levels in marmosets. These studies revealed that compounds with similar SQS inhibitory activities can possess different in vivo durations of action and lipid-lowering abilities.
引用
收藏
页码:3274 / 3281
页数:8
相关论文
共 21 条
[1]   THE SQUALESTATINS - CLEAVAGE OF THE BICYCLIC CORE VIA THE NOVEL 2,8,9-TRIOXABICYCLO[3.3.1]NONANE RING-SYSTEM [J].
ANDREOTTI, D ;
PROCOPIOU, PA ;
WATSON, NS .
TETRAHEDRON LETTERS, 1994, 35 (11) :1789-1792
[2]   A GENERAL PROCEDURE FOR THE SYNTHESIS OF ISOXAZOLIDIN-5-ONES [J].
BALDWIN, JE ;
HARWOOD, LM ;
LOMBARD, MJ .
TETRAHEDRON, 1984, 40 (21) :4363-4370
[3]  
BAXTER A, 1992, J BIOL CHEM, V267, P11705
[4]   ZARAGOZIC ACIDS - A FAMILY OF FUNGAL METABOLITES THAT ARE PICOMOLAR COMPETITIVE INHIBITORS OF SQUALENE SYNTHASE [J].
BERGSTROM, JD ;
KURTZ, MM ;
REW, DJ ;
AMEND, AM ;
KARKAS, JD ;
BOSTEDOR, RG ;
BANSAL, VS ;
DUFRESNE, C ;
VANMIDDLESWORTH, FL ;
HENSENS, OD ;
LIESCH, JM ;
ZINK, DL ;
WILSON, KE ;
ONISHI, J ;
MILLIGAN, JA ;
BILLS, G ;
KAPLAN, L ;
OMSTEAD, MN ;
JENKINS, RG ;
HUANG, L ;
MEINZ, MS ;
QUINN, L ;
BURG, RW ;
KONG, YL ;
MOCHALES, S ;
MOJENA, M ;
MARTIN, I ;
PELAEZ, F ;
DIEZ, MT ;
ALBERTS, AW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) :80-84
[5]  
BILLER SA, 1992, RECENT ADV DRUGS TRE
[6]  
BLOWS WM, 1994, J ANTIBIOT, V47, P741
[7]   THE SQUALESTATINS - C-3 DECARBOXYLATION STUDIES AND REARRANGEMENT TO THE 6,8-DIOXABICYCLO[3.2.1]OCTANE RING-SYSTEM [J].
CHAN, C ;
INGLIS, GGA ;
PROCOPIOU, PA ;
ROSS, BC ;
SRIKANTHA, ARP ;
WATSON, NS .
TETRAHEDRON LETTERS, 1993, 34 (38) :6143-6146
[8]   THE SQUALESTATINS, NOVEL INHIBITORS OF SQUALENE SYNTHASE PRODUCED BY A SPECIES OF PHOMA .1. TAXONOMY, FERMENTATION, ISOLATION, PHYSICOCHEMICAL PROPERTIES AND BIOLOGICAL-ACTIVITY [J].
DAWSON, MJ ;
FARTHING, JE ;
MARSHALL, PS ;
MIDDLETON, RF ;
ONEILL, MJ ;
SHUTTLEWORTH, A ;
STYLLI, C ;
TAIT, RM ;
TAYLOR, PM ;
WILDMAN, HG ;
BUSS, AD ;
LANGLEY, D ;
HAYES, MV .
JOURNAL OF ANTIBIOTICS, 1992, 45 (05) :639-647
[9]  
de Montellano P R, 1977, J Med Chem, V20, P243
[10]   SEMISYNTHETIC SQUALESTATINS - SQUALENE SYNTHASE INHIBITION AND ANTIFUNGAL ACTIVITY - THE SAR OF C6 AND C7 MODIFICATIONS [J].
GIBLIN, GMP ;
BELL, R ;
HANCOCK, AP ;
HARTLEY, CD ;
INGLIS, GGA ;
PAYNE, JJ ;
PROCOPIOU, PA ;
SHINGLER, AH ;
SMITH, C ;
SPOONER, SJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (12) :2605-2610